Effect of soybean and fish liver oil on control of hot flashes, sexual disorders and sleep disorders

Phase 3

Conditions: Menopause.
Menopausal and female climacteric states
N95.1

Registration Number: IRCT20200222046584N1

Lead Sponsor: Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 159

Inclusion Criteria

Ages between 45 and 64 years
Not allergic to soy and fish liver pills
Having informed consent for inclusion

Exclusion Criteria

Lack of reading and writing skills and unable to answer questions
No phone calls to follow up
Having a history of more than 10 years of menopause
Concomitant use of sulfanamides, methotrexate, triamethrenone, sulfasalazine, estrogen, phenytoin, anti-anxiety and antidepressants, daily chemicals and multivitamins, aspirin and painkillers
Hormone therapy and OCP use over the past 3 months
Use of complementary herbs to remove vasomotor symptoms over the past month
Contraindications to hormone therapy include suspected or diagnosed cancer

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of the effect of soy tablets and fish liver oil on TSH level. Timepoint: Before and after the intervention. Method of measurement: TSH measurement in blood.;Comparison of the effect of soy and liver oil pill on lipid profile. Timepoint: Before and after the intervention. Method of measurement: lipid profile measurement in blood.;Measuring the number of hot flashes. Timepoint: Before and after the intervention. Method of measurement: Patient MRS questionnaire.;Measuring the number of times a patient wakes up. Timepoint: Before and after the intervention. Method of measurement: Patient MRS questionnaire.;Patient's sexual reluctance. Timepoint: Before and after the intervention. Method of measurement: Patient MRS questionnaire.;Vaginal dryness. Timepoint: Before and after the intervention. Method of measurement: Patient MRS questionnaire.

Secondary Outcome Measures